GO:0032570 response to progesterone: Hormone Signaling, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0032570 (response to progesterone) describes any cellular or organismal change triggered by a progesterone stimulus, including altered gene expression, secretion, movement, and enzyme production.
Progesterone responses are tissue-specific and include uterine preparation for implantation, mammary gland transcriptional reprogramming, sperm acrosome reaction, and ovarian granulosa cell steroidogenesis [1,3,6,8].
The progesterone receptor (PGR) is the central transcription factor mediating canonical progesterone responses, and its expression can be modulated by cell cycle regulators such as cyclin D1.
Progesterone signaling in the tumor microenvironment influences endometrial cancer response to hormonal therapy, making this pathway clinically actionable.
Neonatal progesterone exposure can program adult uterine responses and alter susceptibility to uterine dysfunction, demonstrating developmental plasticity of this process.
CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of genes involved in progesterone response for reproductive biology and cancer research.

Description

Response to progesterone (GO:0032570) is a biological process defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus. Progesterone is a steroid hormone critical for reproductive physiology, and its effects span diverse tissues including the uterus, mammary gland, ovary, and sperm [1,3,6,8]. Understanding this process at the molecular level is essential for reproductive biology, cancer endocrinology, and developmental programming research.

response to progesterone At A Glance

GO ID GO:0032570
GO term response to progesterone
Ontology biological_process
Synonym response to progesterone stimulus
Major function Mediates cellular and organismal changes triggered by progesterone, including gene expression, secretion, and movement
Definition source QuickGO
Related stimuli Progesterone, progestins, synthetic progestogens
Key mediator Progesterone receptor (PGR)
Tissue examples Uterus, mammary gland, ovary, sperm

What Is GO:0032570?

GO:0032570 (response to progesterone) encompasses all molecular, cellular, and physiological changes that occur when a cell or organism encounters progesterone. This includes rapid non-genomic effects such as ion flux changes in sperm, as well as slower genomic effects involving transcriptional reprogramming in the uterus and mammary gland [1,3]. The term captures outcomes such as altered secretion, enzyme production, cell movement, and gene expression following progesterone stimulation.

Why Is response to progesterone Important in Cell Biology?

Response to progesterone is fundamental to female reproductive health, fertility, and pregnancy maintenance, and its dysregulation contributes to endometrial cancer, uterine dysfunction, and infertility [4,7]. Because progesterone responses are tissue-specific and temporally dynamic, researchers need robust experimental models to dissect the underlying gene regulatory networks and identify therapeutic targets.
Essential for uterine preparation and receptivity during the menstrual cycle and early pregnancy.
Drives transcriptional programs in the mammary gland that influence breast development and cancer risk.
Regulates ovarian granulosa cell proliferation and progesterone production, impacting fertility.
Controls sperm acrosome reaction, a critical step in fertilization.
Influences endometrial cancer response to hormonal therapy through microenvironment signaling.
Neonatal progesterone exposure can program adult uterine function and disease susceptibility.
Cyclin D1 modulates progesterone receptor expression, linking cell cycle control to hormone responsiveness.
Serum progesterone levels and estradiol response impact IVF-ET outcomes.
Provides a model for studying steroid hormone action and gene regulation.
Offers targets for contraceptive and hormone therapy development.

What Happens During response to progesterone?

Progesterone Binding and Receptor Activation
In simple terms: Progesterone acts like a key that fits into the progesterone receptor, turning it on.
Progesterone binds to the progesterone receptor (PGR), triggering conformational changes that allow receptor dimerization and translocation to the nucleus. This initiates transcriptional regulation of target genes [2,3]. In sperm, progesterone can also act via non-genomic pathways to alter intracellular pH and promote the acrosome reaction.
Transcriptional Reprogramming
In simple terms: Activated receptors switch genes on or off, changing cell behavior.
In the mammary gland, acute progesterone exposure leads to widespread changes in gene expression, including upregulation of signaling pathways and cell cycle regulators. In the uterus, progesterone induces genes required for implantation and secretory function. Cyclin D1 can enhance progesterone receptor expression, amplifying the transcriptional response.
Cellular and Physiological Outcomes
In simple terms: The gene changes lead to visible effects like secretion, movement, or cell growth.
Progesterone response manifests as increased secretion in the uterus, altered cell proliferation in ovarian granulosa cells, and changes in sperm motility and acrosomal exocytosis. In endometrial cancer, progesterone signaling in the microenvironment can influence tumor response to hormonal therapy.
Developmental Programming
In simple terms: Early-life exposure to progesterone can have lasting effects on how the body responds later.
Neonatal progesterone exposure in rodents programs adult uterine responses to progesterone, altering susceptibility to uterine dysfunction. This highlights the long-term impact of progesterone during critical developmental windows.

Key Genes Involved in GO:0032570 response to progesterone

The following genes and proteins are central to progesterone response, as supported by published literature.
GeneMajor RoleResearch Relevance
PGRProgesterone receptor; mediates canonical genomic and non-genomic progesterone signalingCore mediator of GO:0032570; target for hormonal therapy [2,4]
CCND1Cyclin D1; regulates progesterone receptor expression and enhances response to estrogen and progesteroneLinks cell cycle to hormone responsiveness
ESR1Estrogen receptor alpha; cross-talks with progesterone signalingModulates progesterone response in reproductive tissues
PRLProlactin; involved in mammary gland development and progesterone responseContext-dependent modulator
WNT4Wingless-type MMTV integration site family member 4; mediates progesterone-induced uterine signalingImplicated in uterine function
LIFLeukemia inhibitory factor; progesterone-regulated cytokine essential for implantationMarker of uterine receptivity
HAND2Heart and neural crest derivatives expressed 2; transcription factor regulated by progesterone in uterusMediates progesterone effects on uterine stroma
FKBP5FK506 binding protein 5; progesterone-responsive geneBiomarker of progesterone action
SGK1Serum/glucocorticoid regulated kinase 1; progesterone-induced kinaseIon transport and cell survival
AREGAmphiregulin; progesterone-regulated growth factorMediates paracrine signaling in mammary gland
RANKLReceptor activator of NF-kB ligand; progesterone-induced in mammary glandStem cell regulation and carcinogenesis
CXCL12C-X-C motif chemokine ligand 12; involved in endometrial cancer microenvironmentModulates hormonal therapy response
MMP7Matrix metallopeptidase 7; progesterone-regulated in uterusTissue remodeling
ITGB1Integrin beta 1; mediates sperm-progesterone interactionsAcrosome reaction
CATSPERCation channel sperm associated; involved in progesterone-induced calcium influxSperm motility and fertilization
ZP3Zona pellucida glycoprotein 3; interacts with progesterone signaling in spermAcrosome reaction
GNRH1Gonadotropin-releasing hormone 1; upstream regulator of ovarian progesterone productionGranulosa cell function

How Is response to progesterone Regulated?

Progesterone response is regulated at multiple levels. Receptor availability is controlled by transcriptional regulation of PGR, which can be enhanced by cyclin D1. In the uterus, neonatal exposure to progesterone can permanently alter the expression of progesterone-responsive genes, indicating epigenetic programming. In ovarian granulosa cells, gonadotropins and insulin-like growth factor I modulate progesterone production, linking systemic endocrine signals to cellular responses. Additionally, in sperm, cholesterol content regulates intracellular pH and the acrosome reaction in response to progesterone.

response to progesterone and Human Disease

GeneDisease / BiologyPotential Experimental Model
PGREndometrial cancer, breast cancer, uterine dysfunctionPGR knockout and point-mutation cell lines; xenograft models [4,7]
CCND1Breast cancer, hormone responsivenessCCND1 overexpression and knockout in mammary epithelial cells
HAND2Uterine dysfunction, implantation failureHAND2 conditional knockout mice
CXCL12Endometrial cancer microenvironmentCXCL12 knockout in endometrial cancer cell lines
FKBP5Progesterone resistance, cancerFKBP5 reporter assays and knockout models
Endometrial Cancer
Progesterone receptor signaling in the tumor microenvironment influences endometrial cancer response to hormonal therapy. Loss of progesterone responsiveness is associated with poor prognosis and resistance to endocrine treatment. Targeting pathways that restore progesterone sensitivity may improve therapeutic outcomes.
Uterine Dysfunction and Infertility
Disrupted progesterone response in the uterus can lead to implantation failure and infertility. Neonatal progesterone exposure programs adult uterine dysfunction in animal models, suggesting developmental origins of uterine disease. Understanding these mechanisms may inform fertility treatments.
Breast Cancer
Progesterone and its receptor play complex roles in mammary gland biology and breast cancer. Acute progesterone exposure induces transcriptional programs that can promote proliferation and stem cell expansion, potentially contributing to tumorigenesis. Cyclin D1, a known oncogene, enhances progesterone receptor expression, linking cell cycle deregulation to hormone-driven cancers.

From response to progesterone-Related Genes to Experimental Models

Research QuestionSuitable Model
Does PGR mediate progesterone-induced gene expression?PGR knockout cell lines (e.g., endometrial cancer cells)
How does cyclin D1 regulate progesterone receptor levels?CCND1 overexpression and knockout in mammary epithelial cells
What is the role of HAND2 in uterine progesterone response?HAND2 conditional knockout mouse
Does a specific point mutation in PGR alter ligand binding?PGR point-mutation knock-in cell lines
Can progesterone response be monitored in real time?Tagged PGR knock-in with fluorescent reporter
What genes are essential for sperm acrosome reaction?CATSPER knockout sperm models

How to Study the response to progesterone Process

MethodWhat It MeasuresTypical Application
RNA-seqGlobal gene expression changesIdentify progesterone-regulated genes
ChIP-seqProgesterone receptor binding sitesMap genomic targets of PGR
ProteomicsProtein abundance and modificationsDiscover non-genomic signaling
CRISPR screenGene essentiality for progesterone responseIdentify resistance mechanisms
Live-cell imagingReceptor localization and dynamicsStudy PGR trafficking
Reporter assaysTranscriptional activity of PGRTest point mutations
ELISAProgesterone levels in serumIVF-ET monitoring
Flow cytometryCell cycle and apoptosisAssess proliferative response
Transcriptomics (RNA-seq)
RNA sequencing after progesterone stimulation identifies global transcriptional changes, revealing target genes and pathways. This approach has been used to map the mammary gland response to acute progesterone exposure and uterine responses.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics can quantify changes in protein abundance and phosphorylation following progesterone treatment, uncovering non-genomic signaling events and post-translational modifications.
Imaging and Live-Cell Tracking
Fluorescently tagged progesterone receptors and reporter cell lines enable real-time visualization of receptor trafficking and transcriptional activity. This is useful for studying dynamic responses in sperm and uterine cells.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that modulate progesterone sensitivity or resistance, providing unbiased discovery of novel regulators.

How CRISPR Can Be Used to Study GO:0032570 response to progesterone

Knockout

CRISPR knockout of PGR or downstream effectors (e.g., HAND2, CXCL12) in cell lines or organoids can abolish progesterone response, confirming their essential roles. For example, PGR knockout in endometrial cancer cells can reverse hormonal therapy sensitivity.

Point Mutation

Introducing specific point mutations in PGR (e.g., ligand-binding domain) via CRISPR base editing or HDR can dissect structure-function relationships and identify mutations that cause hormone resistance.

Knock-in

Knock-in of tagged PGR (e.g., GFP or luciferase) allows real-time monitoring of receptor expression and activity in live cells, facilitating drug screening and dynamic studies.

Overexpression

CRISPR activation (CRISPRa) or lentiviral overexpression of PGR or cyclin D1 can enhance progesterone response, modeling hormone-driven cancers and identifying sensitizing mechanisms.

How EDITGENE Supports response to progesterone Research

Researchers studying response to progesterone-related genes often need to determine whether a candidate gene is causally involved in hormone signaling, whether a specific mutation alters receptor function, or whether overexpression sensitizes cells to progesterone. EDITGENE provides end-to-end CRISPR solutions to answer these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for response to progesterone research.

Frequently Asked Questions About response to progesterone

GO:0032570 is a Gene Ontology biological process term describing any cellular or organismal change triggered by a progesterone stimulus, including gene expression, secretion, and movement.
Key genes include PGR (progesterone receptor), CCND1, HAND2, FKBP5, and CXCL12, among others [2,4,7].
Progesterone binds PGR, causing receptor activation, nuclear translocation, and transcriptional regulation of target genes [2,3].
Endometrial cancer, uterine dysfunction, infertility, and breast cancer are associated with altered progesterone responses [4,7].
Common methods include RNA-seq, ChIP-seq, CRISPR screens, and reporter assays [3,4].
Cyclin D1 enhances progesterone receptor expression and amplifies the response to estrogen and progesterone.
Yes, neonatal progesterone exposure in mice programs adult uterine responses and susceptibility to dysfunction.
The acrosome reaction is a sperm exocytotic event essential for fertilization; progesterone triggers it via non-genomic pathways involving intracellular pH changes.
Acute progesterone exposure induces widespread transcriptional changes in the mammary gland, influencing proliferation and stem cell activity.
EDITGENE offers knockout, point mutation, knock-in, overexpression, and library screening services for genes in this pathway.

Conclusion

Response to progesterone (GO:0032570) is a multifaceted biological process essential for reproduction, development, and tissue homeostasis. Its dysregulation underlies several diseases, including endometrial cancer and uterine dysfunction. By leveraging CRISPR-based models and multi-omics approaches, researchers can dissect the precise molecular players and develop targeted therapies.

References

  1. 1. Groothuis PG et al.. 1997. Uterine response to progesterone in prepubertal gilts.. J Reprod Fertil 110(2):237-43 PMID: 9306976
  2. 2. Yang C et al.. 2010. Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression.. Mol Cell Biol 30(12):3111-25 PMID: 20404095
  3. 3. Fernandez-Valdivia R et al.. 2008. Transcriptional response of the murine mammary gland to acute progesterone exposure.. Endocrinology 149(12):6236-50 PMID: 18687774
  4. 4. Janzen DM et al.. 2013. Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy.. Cancer Res 73(15):4697-710 PMID: 23744837
  5. 5. Lindheim SR et al.. 1999. Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles.. J Assist Reprod Genet 16(5):242-6 PMID: 10335470
  6. 6. Onagbesan OM et al.. 1999. Differential effects of amount of feeding on cell proliferation and progesterone production in response to gonadotrophins and insulin-like growth factor I by ovarian granulosa cells of broiler breeder chickens selected for fatness or leanness.. J Reprod Fertil 116(1):73-85 PMID: 10505058
  7. 7. Dhakal P et al.. 2015. Neonatal Progesterone Programs Adult Uterine Responses to Progesterone and Susceptibility to Uterine Dysfunction.. Endocrinology 156(10):3791-803 PMID: 26204463
  8. 8. Cross NL et al.. 1997. Control of human sperm intracellular pH by cholesterol and its relationship to the response of the acrosome to progesterone.. Biol Reprod 56(5):1169-74 PMID: 9160715
Contact Us
*
*
*
*
How did you hear about us: